Anifrolumab Scores in Sjogren's Phase 2 Trial
Dr. Yuz Yusof reports on abstract OP002 presented at the EULAR 2026 Congress in London
Search for Terms or Answers
Search for Terms or Answers
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.